Nine Lives: Alcon’s Pataday Brochure Draws Yet Another FDA Letter

This article was originally published in The Pink Sheet Daily

28 Feb 2013
News

Executive Summary

FDA’s most recent advertising letter to Alcon about its marketing practices makes the ninth such letter sent to the ophthalmology-focused firm in roughly 10 years; this time, the Office of Prescription Drug Promotion says the Novartis unit has omitted material facts and overstated efficacy and superiority in a brochure for Pataday.

Already Registered? Sign in to continue reading.

New to Pink Sheet? Start a free trial today!

Table
View full table

Topics

United States

Subjects
Advertising, Marketing & Sales

Related Companies

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

BioPharmaceutical United States Advertising, Marketing & Sales

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

PS075336

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

PS075336

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

Nine Lives: Alcon’s Pataday Brochure Draws Yet Another FDA Letter

News

Executive Summary

Related Content

‘Tis The Season… For An FDA Enforcement Letter To Alcon

Rebate Card For Alcon’s Pataday Is More Than Meets The Eye, FDA Says

Topics

Related Companies

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Sign In To Set a Search Alert